From: Defining the optimal dose of radiation in leukemic patients with extramedullary lesions
Factors | Mean Volume Reduction Rate (%) | p -value | |
---|---|---|---|
Primary disease | Yes | 75.0 | 0.077 |
AML | No | 56.9 | Â |
RT site | Yes | 75.7 | 0.254 |
Soft tissue | No | 64.1 | Â |
Concurrent | Yes | 78.7 | 0.248 |
Chemotherapy | No | 65.3 | Â |
Initial size | Yes | 48.4 | 0.065 |
BP ≥ 30 cm2 | No | 72.5 |  |
Initial size | Yes | 58.5 | 0.175 |
LD ≥ 6.0 cm | No | 73.0 |  |
Follow up time | Yes | 69.0 | 0.877 |
≥ 2 weeks | No | 67.3 |  |
Total dose | Yes | 76.6 | 0.178 |
≥ 25 Gy | No | 63.0 |  |
BED10 | Yes | 76.9 | 0.140 |
≥ 30 Gy | No | 62.2 |  |